Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Current Treatment Options in Oncology|August 10, 2019
Advanced Imaging Modalities to Monitor for CardiotoxicityAndreas Seraphim, Mark Westwood, Anish N Bhuva, et al.
Blood|January 8, 2010
Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fractionDavid C Taussig, Jacques Vargaftig, Farideh Miraki-Moud, et al.
Blood|June 5, 2008
Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cellsDavid C Taussig, Farideh Miraki-Moud, Fernando Anjos-Afonso, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 2013
Acute myeloid leukemia does not deplete normal hematopoietic stem cells but induces cytopenias by impeding their differentiationFarideh Miraki-Moud, Fernando Anjos-Afonso, Katharine A Hodby, et al.
The New England Journal of Medicine|June 3, 2015
Elotuzumab Therapy for Relapsed or Refractory Multiple MyelomaSagar Lonial, Meletios Dimopoulos, Antonio Palumbo, et al.
Blood Cancer Journal|September 5, 2020
Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 studyMeletios A Dimopoulos, Sagar Lonial, Darrell White, et al.
Blood|September 6, 2018
RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signatureMichael A Chapman, Jonathan Sive, John Ambrose, et al.
Pageof 2